FDA Proposes to Ease Rules for Pharmaceutical Ads on Social Media
January 28, 2014
Recently, the Food and Drug Administration issued a draft guidance that proposes to make advertising prescription products on social media less burdensome. Comments are due on the FDA’s draft guidance within ninety days.
Members Only Content
This content is available to ANA Members only. Please login below or create an account.
You may already be a member. Find out if your company is already an ANA member.